Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-026310
Filing Date
2024-08-13
Accepted
2024-08-13 13:57:35
Documents
64
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bcda20240630_10q.htm   iXBRL 10-Q 764162
2 EXHIBIT 31.1 ex_709221.htm EX-31.1 11014
3 EXHIBIT 31.2 ex_709222.htm EX-31.2 11196
4 EXHIBIT 32.1 ex_709223.htm EX-32.1 4105
5 EXHIBIT 32.2 ex_709224.htm EX-32.2 4104
6 EXHIBIT 99.1 ex_710110.htm EX-99.1 117660
7 EXHIBIT 99.2 ex_710111.htm EX-99.2 16589
8 EXHIBIT 99.3 ex_710112.htm EX-99.3 20346
  Complete submission text file 0001437749-24-026310.txt   4075426

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA bcda-20240630.xsd EX-101.SCH 41100
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcda-20240630_def.xml EX-101.DEF 252387
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcda-20240630_lab.xml EX-101.LAB 223441
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcda-20240630_pre.xml EX-101.PRE 278100
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcda-20240630_cal.xml EX-101.CAL 28307
67 EXTRACTED XBRL INSTANCE DOCUMENT bcda20240630_10q_htm.xml XML 541251
Mailing Address 320 SOQUEL WAY SUNNYVALE CA 94085
Business Address 320 SOQUEL WAY SUNNYVALE CA 94085 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

EIN.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38999 | Film No.: 241200425
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)